- Home
- AMPY vs NVCT Comparison
AMPY vs NVCT Comparison
Compare AMPY & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMPY | NVCT |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.2M | 220.0M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AMPY | NVCT |
|---|---|---|
| Price | $6.01 | $8.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 821.3K | 47.0K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 232.26 | N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $208,637,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.83 | N/A |
| P/E Ratio | $5.84 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.53 | $5.55 |
| 52 Week High | $6.79 | $10.82 |
Technical Indicators
Market Signals| Indicator | AMPY | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 56.60 | 54.52 |
| Support Level | $5.09 | $8.08 |
| Resistance Level | $6.71 | $9.20 |
| Average True Range (ATR) | 0.23 | 0.40 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 83.33 | 59.85 |
Price Performance
Historical ComparisonAbout AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.